Description
BSE announces the upcoming listing of equity shares of Gaudium IVF and Women Health Limited (Scrip Code: 544709, Symbol: GAUDIUMIVF) on the SME segment. The exact listing date will be communicated via a separate notice.
Summary
BSE has notified trading members that the equity shares of Gaudium IVF and Women Health Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned Scrip Code 544709, trading symbol GAUDIUMIVF, and ISIN INE0P8B01020 under the SME segment.
Key Points
- Gaudium IVF and Women Health Limited is being listed on BSE under the SME segment
- Scrip Code: 544709
- Trading Symbol: GAUDIUMIVF
- ISIN: INE0P8B01020
- The exact date of listing and further security details will be communicated through a separate notice
Regulatory Changes
No regulatory changes involved. This is a standard new listing announcement under BSE’s SME platform.
Compliance Requirements
Trading members are advised to take note of the upcoming listing. Further compliance and trading guidelines will be issued alongside the listing date notice.
Important Dates
- Circular Date: February 26, 2026
- Listing Date: To be announced via a separate notice
Impact Assessment
This listing expands the SME segment on BSE with a healthcare-focused company operating in the IVF and women’s health sector. The announcement is informational at this stage; the actual market impact will be assessed once the listing date and security details are formally notified. Traders interested in the SME segment should monitor for the follow-up notice confirming the listing date.
Impact Justification
New SME segment listing announcement; relevant to traders and investors interested in the scrip, but the actual listing date is yet to be announced via a separate notice.